Skip to content

4 weeks

5 trials

Sponsors

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Seiichiro Aoe Otsuma Womens University Faculty of Home Economics Department Food Science, Universidade Federal de Pernambuco, The graduate school of Srinakharinwirot University

Conditions

1.Defecation frequency: more than 2times and less than 5times/week 2. Body mass index(BMI): more than 20 and less than 30Chronic fatigue syndromeChronic insomniaElderlyPeripheral neuropathy&#44

Phase 3

Unknown Phase

Nutritional Assistance Study in Overweight Elderly submitted to Bodybuilding Training
Active, not recruitingRBR-6xfzht
Universidade Federal de PernambucoElderly
Start: 2018-02-10Updated: 2025-10-27
A randomized, double-blind, positive drug parallel control and multi-center clinical trial on the protection of traditional Chinese medicine varieties for the effectiveness and safety of Yining Pills in the treatment of chronic insomnia (qi and blood deficiency and liver and kidney deficiency)
Active, not recruitingChiCTR2200061625
Beijing Hospital of Traditional Chinese Medicine, Capital Medical UniversityChronic insomnia
Start: 2022-06-16Updated: 2023-04-03
Yi'anning pill is a randomized, double-blind, positive drug parallel control and multi-center clinical trial for the protection of traditional Chinese medicine varieties for the efficacy and safety of the treatment of chronic fatigue syndrome (qi and blood deficiency and liver and kidney deficiency)
Active, not recruitingChiCTR2200061653
Beijing Hospital of Traditional Chinese Medicine, Capital Medical UniversityChronic fatigue syndrome
Start: 2022-06-16Updated: 2023-04-03
Evaluation of an effect on human intestinal microbiota with taking of okara powder in a randomized double-blind study
Active, not recruitingJPRN-UMIN000049294
Seiichiro Aoe Otsuma Womens University Faculty of Home Economics Department Food Science1.Defecation frequency: more than 2times and less than 5times/week 2. Body mass index(BMI): more than 20 and less than 30
Start: 2022-10-31Target: 24Updated: 2025-11-17